Context: Recreational fishing is regulated in 2 broad ways: natural resource-based management of fish stocks referred to here as "catch regulations," and public heath-based fish consumption advisories to reduce risks to humans from exposures to pollutants referred to as "consumption advisories."
Objective: To examine the extent to which state regulatory agencies present recreational fish catch regulations and consumption advisories together and develop an ecologically based, public health argument for why these fishing regulations and advisories could be joined.
Design: State-level catch regulations and consumption advisories were collected from 50 US states and analyzed for a variety of factors.
Main Outcome Measure: Correlation between catch regulations and consumption advisories, by aquatic animal species and taxonomic family, and by state, were the main outcome measures.
Results: State-level catch regulations were strongly predictive of state-level consumption advisories, by species (R = 0.87) or taxonomic family (R = 0.91). Within each state, however, fish catch regulations and consumption advisories were presented together in less than half of fishing guides.
Conclusion: Fish advisories and regulations are often produced by separate state regulatory agencies, indicating an opportunity for interagency collaboration to improve health communication messaging regarding recreational fishing and self-caught fish consumption.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PHH.0b013e3182602fa9 | DOI Listing |
Nutrients
January 2025
School of Psychology, University of Sheffield, Sheffield S10 2TN, UK.
Background: The average fibre consumption of 4-10-year-old children in the UK is 14.6 g per day, with only 14% of these children reaching the 20 g recommended by the SACN (UK Scientific Advisory Committee on Nutrition), and this 'fibre gap' may be most pronounced in communities with the lowest socioeconomic status. School breakfast clubs target children from disadvantaged communities, but their provision may favour lower-fibre foods, due to perceptions that children will reject higher-fibre foods.
View Article and Find Full Text PDFFarm Hosp
January 2025
Servicio de Farmacia, Hospital Universitario Puerto Real, Cádiz, Spain.
The objective of regulatory authorities is to ensure a favourable risk-benefit balance for medicines in their licenced indication, without seeking to establish their place in the therapeutic armamentarium beyond that. The licenced indication covers heterogeneous subpopulations and often does not sufficiently specify the characteristics of the patients who may benefit. The regulatory information does not always show the benefit over the standard treatment(s); moreover, it only reacts to the conditions specified in the developer's application, and lacks an assessment of the clinical relevance of the benefit and its uncertainties.
View Article and Find Full Text PDFEpidemiology
January 2025
Department of Public Health, Aarhus University, Aarhus, DK.
Background: Improvements in breast cancer therapy since the randomized controlled trials of mammography screening might have reduced the screening benefit. Most observational studies of mammography effectiveness would be confounded by these improvements and other factors. Using a design resistant to this confounding, we evaluated whether mammography in asymptomatic women reduces breast cancer mortality during the treatment era succeeding the trials.
View Article and Find Full Text PDFPLoS One
January 2025
French National Reference Center for Primary Immunodeficiencies (CEREDIH) and Pediatric Immunology, Hematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
Background: Subcutaneous immunoglobulin (SCIg) replacement therapy is indicated for patients with hypogammaglobulinemia caused by primary (PID) and secondary immunodeficiencies (SID).
Objective: To compare healthcare resource utilization (HCRU) and related direct medical costs of patients in France treated with weekly conventional SCIg (cSCIg) vs monthly hyaluronidase-facilitated SCIg (fSCIg).
Methods: This retrospective study of Ig-naïve patients with PID or SID newly receiving a SCIg between 2016 and 2018, extracted from the French National Healthcare reimbursement database (SNDS), analyzed the SCIg-related HCRU and reimbursed costs generated from in-hospital (hospitalizations and SCIg doses) or at-home (nurse visits [NV] and pump provider visits [PPV], drug doses) SCIg administration.
Front Public Health
January 2025
Dermatology Department, Colentina Clinical Hospital, Bucharest, Romania.
Introduction: Atopic dermatitis (AD), a common dermatological condition, is often associated with significant economic and social burdens. Despite extensive studies globally, there is a gap in understanding the impact of this condition in Romania. This study evaluated the economic burden of AD in Romania, considering both direct and indirect costs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!